IONS files Rule 144 notice for 68,800 shares

IONS notice of proposed sale of 68,800 shares of Common Stock under Rule 144.

Rhea-AI Filing Summary

IONS notice of proposed sale of 68,800 shares of Common Stock under Rule 144. The form lists a sale venue as Nasdaq and an effective/filing date of 03/03/2026. The excerpt also shows 50,432 shares from an option exercise and 18,368 RSUs with grant dates.

Insights

Securities Compliance Specialist

Rule 144 sale notice for 68,800 shares; lists sources including exercised options and RSUs.

The filing is a procedural disclosure that lists the number of shares the holder proposes to sell: 68,800 shares with Nasdaq cited as the market and 03/03/2026 as the form date. The entry shows underlying holdings from an Option Exercise (50,432 shares) and Restricted Stock Units (18,368 shares).

Because this is a Rule 144 notice, it does not itself confirm completed trades or proceeds. Timing, broker details, and whether sales have occurred are not shown in the excerpt; subsequent transaction reports would show execution details.

Key Figures

Proposed shares to sell: 68,800 shares Market listed: Nasdaq Form date: 03/03/2026 +3 more

6 metrics

Proposed shares to sell 68,800 shares Form 144 entry

Market listed Nasdaq Securities To Be Sold section

Form date 03/03/2026 Filer Information / Securities sections

Option exercise shares 50,432 shares Option Exercise source dated 07/01/2021

Restricted Stock Units 18,368 shares RSU grant dated 01/15/2021

Dollar value listed $5,469,600.00 Numeric field adjacent to securities (as shown)

Key Terms

Restricted Stock Units, Option Exercise, Rule 144

3 terms

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 18368 | 01/15/2021"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Option Exercise financial

"Option Exercise | Issuer | 50432 | 03/03/2026"

Rule 144 regulatory

"144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the IONS Form 144 disclose?

The Form 144 discloses a proposed sale of 68,800 shares of Common Stock with Nasdaq listed as the market and a filing date of 03/03/2026. It also lists underlying sources: 50,432 option-exercised shares and 18,368 RSUs.

Does the Form 144 mean the shares were sold for IONS?

No. The Form 144 is a notice of intention to sell up to 68,800 shares; it does not confirm execution. Trade execution, sale price, and proceeds would appear in subsequent trade confirmations or different SEC reports.

What securities sources are listed on the IONS excerpt?

The excerpt lists securities from an Option Exercise dated 07/01/2021 showing 50,432 shares and Restricted Stock Units dated 01/15/2021 showing 18,368 shares, both referenced as equity compensation sources.

What market and date appear on the IONS Form 144?

The filing shows the intended trading market as Nasdaq and includes a form/filing date of 03/03/2026. Those are disclosure elements on the notice and do not by themselves indicate executed trades.

Will the Form 144 reveal sale proceeds or prices for IONS?

No. The Form 144 lists quantities and intended sale venue but does not provide sale prices or proceeds. Completed trade details would appear in subsequent broker reports or other SEC transaction filings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/31/2026 - 05:28 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001773314
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IONIS PHARMACEUTICALS INC
SEC File Number	000-19125
Address of Issuer	2855 GAZELLE COURT CARLSBAD CALIFORNIA 92010
Phone	7609319200
Name of Person for Whose Account the Securities are To Be Sold	Diaz Allene M.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	68800	5469600.00	161970000	03/03/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/01/2021	Option Exercise	Issuer			50432	03/03/2026	Cash
Common Stock	01/15/2021	Restricted Stock Units	Issuer			18368	01/15/2021	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/31/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Weimer, as a duly authorized representative of STIFEL, as attorney-in-fact for Allene Diaz
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)